Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the fastest ...

The results come from five patients enrolled in the biotech's ingoing phase 1/2 study of RGX-111 – which uses an adeno-associated viral vector (AAV9) to deliver a gene coding for an enzyme that ...

Eli Lilly has become a magnet for investor buzz, despite recent stock slippage trailing behind the broader pharma pack. The company’s shares dropped 12.8% in the past month, worse than the industry ...

Eli Lilly shares stumbled 4.2% mid-Wednesday after Morgan Stanley clipped its price target, dropping investor spirits faster than caffeine crashes. Morgan Stanley downgraded the stock’s price target ...

Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials collection Artificial Intelligence Trending searches Video Woman ...